Sign in

Arturo LoAIza-Bonilla, MD MSEd

@drbonillaonc.bsky.social
1.1K followers 852 following 33 posts

Co-founder @MassiveBio | Chief Hem/Onc @mystlukes | Using #tech #AI & #genomics to fight cancer at global scale 🌎 🚀 🧬 🖥️ - My Opinions only

PostsRepliesMedia
Reposted by Arturo LoAIza-Bonilla, MD MSEd
American Society of Clinical Oncology @ascocancer.bsky.social · 01/06/2026
Dr. Arturo Loaiza-Bonilla chairing a session now at #ASCO26 on Tech that Scales: #AI & Digital Tools for Cancer Care in LMICs with panelists Dr. Partha Basu & Dr. Sanjeev Arora. Related material from #ASCOEdBook: bit.ly/4331xeN
021
Reposted by Arturo LoAIza-Bonilla, MD MSEd
OncoDaily @oncodaily.bsky.social · 18/05/2026
AI in Oncology Depends on Transparent and Verifiable Evidence - Arturo LoAlza-Bonilla @drbonillaonc.bsky.social oncodaily.com/voices/artur... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
oncodaily.com
Arturo LoAlza-Bonilla: AI in Oncology Depends on Transparent and Verifiable Evidence - OncoDaily
Arturo LoAlza-Bonilla: AI in Oncology Depends on Transparent and Verifiable Evidence / AI, Arturo Bonilla, Arturo Loaiza-Bonilla, cancer, Chad Levitt, Chadi
011
Reposted by Arturo LoAIza-Bonilla, MD MSEd
OncoDaily @oncodaily.bsky.social · 19/09/2025
Solving the Clinical Trial Enrollment Paradox Using AI and Big Data - Arturo LoAIza-Bonilla @drbonillaonc.bsky.social oncodaily.com/voices/artur... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
oncodaily.com
Arturo LoAIza-Bonilla: Solving the Clinical Trial Enrollment Paradox Using AI and Big Data - OncoDaily
Arturo LoAIza-Bonilla: Solving the Clinical Trial Enrollment Paradox Using AI and Big Data / Arturo Loaiza-Bonilla, ASCO, cancer, OncoDaily, Oncology
031
Reposted by Arturo LoAIza-Bonilla, MD MSEd
NEJM AI @ai.nejm.org · 03/06/2025
Perspective by Arturo Loaiza-Bonilla, MD, MSEd, FACP, and Scott Penberthy, PhD : Harnessing Moravec’s Paradox in Health Care: A New Era of Collaborative Intelligence nejm.ai/4jSWaVV @drbonillaonc.bsky.social #AI #MedSky #MLSky
Figure 1. Moravec’s Paradox in Health Care.
031
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Julie Gralow @jrgralow.bsky.social · 03/06/2025
#asco25 joint @ascocancer.bsky.social @myesmo.bsky.social session on “Biomarker-driven Therapeutics: Translating Innovation into Practice” @drbonillaonc.bsky.social
041
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 29/05/2025
Red lens sunglasses can enhance contrast and depth perception, may also reduce eye fatigue by filtering certain wavelengths and improving visual comfort. After so much screen time in preparation for #ASCO25 this really helps! See you in Chicago!! @ASCO @mystlukes @americancancersoc.bsky.social
020
Reposted by Arturo LoAIza-Bonilla, MD MSEd
OncoDaily @oncodaily.bsky.social · 29/05/2025
Performance Evaluation of an AI-powered System for Clinical Trial Eligibility Using mCODE Data Standards - Yan Leyfman @yleyfman.bsky.social @drbonillaonc.bsky.social @massive-bio.bsky.social oncodaily.com/blog/yan-ley... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AI
oncodaily.com
Yan Leyfman: Performance Evaluation of an AI-powered System For Clinical Trial Eligibility Using mCODE Data Standards - OncoDaily
Yan Leyfman: Performance Evaluation of an AI-powered System For Clinical Trial Eligibility Using mCODE Data Standards / and Cagatay Culcuoglu, Arturo
084
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 17/05/2025
ASCO/ESMO Joint Session at ASCO25 Will Highlight Key Issues in Biomarker-Driven Therapeutics dailynews.ascopubs.org/do/asco-esmo...
dailynews.ascopubs.org
ASCO Daily News
000
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 09/05/2025
Filming day at St. Luke’s! 🎥 From clinical trials to AI-powered care, we’re showcasing how we fight cancer with heart and innovation. 🚀 16 hospitals. Robotic surgery. Advanced radiation. Multiomics + bi-specifics. The most wired health system in the U.S. All for you. #StLukesProud
110
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Nathan Pennell MD, PhD, FASCO @n8pennell.bsky.social · 02/05/2025
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.... #ASCO25 @drbonillaonc.bsky.social
161
Reposted by Arturo LoAIza-Bonilla, MD MSEd
OncoDaily @oncodaily.bsky.social · 02/05/2025
How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support - Arturo LoAIza-Bonilla @drbonillaonc.bsky.social oncodaily.com/blog/arturo-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AI #ASCO25
oncodaily.com
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support - OncoDaily
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support / AI, Arturo Loaiza-Bonilla, ASCO,
061
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 02/05/2025
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10....
ascopubs.org
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology
Artificial intelligence (AI) is transforming multidisciplinary oncology at an unprecedented pace, redefining how clinicians detect, classify, and treat cancer. From earlier and more accurate diagnoses...
010
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 30/04/2025
Thrilled to see my latest article featured in the Spring 2025 issue of llOncolytics Today! 🌟 “Closing the Gaps in Oncology: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support” #ASCO25. See you in Chicago! #PrescreeningHubs
100
Reposted by Arturo LoAIza-Bonilla, MD MSEd
David Shaywitz @dshaywitz.bsky.social · 24/04/2025
Moravec’s paradox also discussed in context of AI & healthcare by @pmarca.tweet.pub in recent thoughtful @a16z.bsky.social pcast, as I wrote about here: timmermanreport.com/2025/02/the-...
timmermanreport.com
The Future of AI and Health, Part II: Andreessen and Colleagues Weigh In - TimmermanReport.com
Part I of this series is here. Over its 15 years of existence, the Andreessen Horowitz (“A16z”) venture capital firm has evolved from a media-savvy disruptive upstart to an exceedingly well-heeled inc...
011
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Eric Topol @erictopol.bsky.social · 24/04/2025
A good discussion of Moravec's paradox in healthcare @NEJM_AI ai.nejm.org/doi/full/10....
ai.nejm.org
Harnessing Moravec’s Paradox in Health Care: A New Era of Collaborative Intelligence
Artificial intelligence excels at complex data analytics, yet struggles with nuanced, sensorimotor tasks that humans perform almost effortlessly — a dichotomy encapsulated by Moravec’s paradox. By ...
1379
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 24/04/2025
Thrilled! Our @ai.nejm.org NEJM AI perspective “Harnessing Moravec’s Paradox in Health Care” - is now live. Grateful for brilliant co-author & friend Scott Penberthy (@scottpenberthy) of @GoogleCloud. Onward to truly collaborative intelligence! 🔗 ai.nejm.org/stoken/defau...
031
Reposted by Arturo LoAIza-Bonilla, MD MSEd
OncoDaily @oncodaily.bsky.social · 08/04/2025
Full day of CME discussing the top research from ASCOGI25 - @drbonillaonc.bsky.social @ascocancer.bsky.social oncodaily.com/url/269641 #OncoDaily #Oncology #Cancer #Health #Medicine #ASCOGI25
oncodaily.com
Arturo LoAIza-Bonilla: Full day of CME discussing the top research from ASCOGI25 - OncoDaily
Arturo LoAIza-Bonilla: Full day of CME discussing the top research from ASCOGI25 / American Society of Clinical Oncology, Arturo Loaiza-Bonilla, ASCO,
081
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 15/03/2025
www.cancernetwork.com/view/investi... - Dr. Regina Barzilay PhD, Ketan Badani MD FRCS and I share some insights on it’s future implementation in cancer care | St. Luke's University Health Network | Massive Bio | Massachusetts Institute of Technology | Mount Sinai Health System #AI #cancer
cancernetwork.com
Investigating the Emergence of Artificial Intelligence on Oncologic Practice
As artificial intelligence has arrived in the oncology field, experts discuss how this new technology can have implications for transforming clinical practice.
000
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 08/03/2025
Great representation of @mystlukes at @LmsaNational NE 2025 meeting!! Appreciate the invitation to hopefully inspire future generations of physicians. Even better when Dr. Israel Zighelboim as faculty! #stlukesproud @MassiveBio | @TUMedResearch @TempleUniv #AI
010
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 12/02/2025
LIVE today discussing the urgent challenges in cancer research and clinical trials due to funding cuts. AI, innovation, & collaboration are key to overcoming these obstacles and driving progress in the field. @MassiveBio Tune in now for key insights! 🎥👇
📺 Watch live: www.youtube.com/watch?v=ar5q...
000
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Massive Bio @massive-bio.bsky.social · 10/02/2025
NIH funding cuts threaten clinical trials and patient access to life-saving treatments. Our Co-Founder & CMO, @drbonillaonc.bsky.social, shares how we can adapt and innovate. Read the open letter 👉 bit.ly/3CyOtnP #Cancer #cancerclinical #clinicaltrials #OpenLetter
bit.ly
An Open Letter to Cancer Centers, Research Institutions, and the Broader Oncology Community
February 2025 Dear Colleagues, In light of the recent developments regarding the The National Institutes of Health’s (NIH) abrupt reduction of indirect cost rates—from historical levels approaching 50...
011
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Massive Bio @massive-bio.bsky.social · 11/02/2025
Massive Bio remains committed to accelerating cancer research and expanding clinical trial access amid the uncertainty surrounding recent NIH funding cuts. The mission to ensure equitable access to innovative cancer care is more critical than ever. Read the full press release: bit.ly/3CIRXEg
011
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 28/01/2025
www.onclive.com/view/artific... This is a long format grand rounds video for OncLive where I share about the advent of #ArtificialIntelligence in #CancerCare and #ClinicalTrials - hope you find it interesting @massive-bio.bsky.social
onclive.com
Artificial Intelligence in Cancer Care and Clinical Trials
Arturo Loaiza-Bonilla, MD, discusses artificial intelligence in cancer care and clinical trials.
010
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 24/01/2025
#AI #LLM #medicaleducation www.medscape.com/viewarticle/...
medscape.com
The Rise of Large Language Models in Medicine: The Next Frontier
In his latest column, Arturo Loaiza-Bonilla, MD, MSEd, explores the latest on large language models in medicine and the new era of medical training and practice.
110
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 15/01/2025
Proud to be in California at the AMA/RUC meeting, representing American Society of Clinical Oncology (ASCO) and all U.S. oncology practices to champion equitable access and fair reimbursement for lifesaving cancer therapies. Thank you to our dedicated ASCO staff for your hard work, and to SLUHN!
011
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 15/01/2025
Proudest moment for Massive Bio on being recognized by The White House Cancer Moonshot for our efforts in helping cancer patients to transform access clinical trials with our AI-enabled platform and scalable pre-screening hubs. Massive thank you to team and all our partners who make this possible!!
020
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 11/01/2025
Fascinating fire chat with @bryan_johnson during our Scrub Capital mtg. Kudos to being bold investing in efforts to understand longevity, epigenetic, biomarkers, aging clocks, human physiology. At @MassiveBio we are taking also a bold innovative approach to transform clinical trials & research!! 🚀
110
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 11/01/2025
Starting 2025 with site visits across our 15-hospitals at @mystlukes and an interview at @WNEP to discuss Surgeon General’s report on the link between alcohol and cancer risks. Committed to awareness and collaboration for screening and access @AmericanCancer - @ASCO - @MassiveBio lnkd.in/e9MwVQhd
030
Reposted by Arturo LoAIza-Bonilla, MD MSEd
The OncoAlert Network 🚨 @oncoalert.bsky.social · 01/01/2025
Happy New Year from OncoAlert @aftimosp.bsky.social @coffeemommy.bsky.social @drjnaidoo.bsky.social @agerikssonmd.bsky.social @jackwestmd.bsky.social @raalbany.bsky.social @drbonillaonc.bsky.social @stephenvliu.bsky.social @darcyburbage.bsky.social @itsnotpink.bsky.social
1124
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 20/12/2024
“Imagine a world where every patient, regardless of geography or socioeconomic status, has access to the best treatment options available – a world where a diagnosis does not come with a stigma or an expiration date, but rather with hope and personalized pathways to wellness”
100
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 18/12/2024
December is a great time to be productive. Last 36 hours: @TelemundoNews interview, system meetings at @mystlukes, @ASCO / @US_FDA meeting, @massive-bio.bsky.social AI lab and platform review with team, @CancerXMoonshot meetup, two manuscripts, one grant, and a Colombian novena! 🚀
020
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 10/12/2024
Really excited to attend the @StanfordAIMI - @Stanford Institute for Human-Centered Artificial Intelligence (HAI) 4th Annual Stanford AI+HEALTH Conference, where we will explore real-world #AI applications across #healthcare. @massive-bio.bsky.social @stanfordmedicine.bsky.social
020
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Massive Bio @massive-bio.bsky.social · 03/12/2024
November is Lung Cancer Awareness Month, a time to highlight the stories of courage and hope from those impacted by lung cancer. Whether you're a #survivor, #caregiver, or someone remembering a loved one, your story has the power to inspire and raise #awareness #LungCancerSurvivor #StrongerTogether
031
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 02/12/2024
I am thrilled to announce my official appointment as Systemwide Chief of Hematology and Oncology at St. Luke's University Health Network @mystlukes and Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University!! @templemedschool
250
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 27/11/2024
Really nice way to end my clinic. Thankful for my patients and colleagues at @capitalhealthnj for a wonderful journey over the last 3 years. Happy Thanksgiving!!
030
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 20/11/2024
November is Men’s Health Awareness Month! Thank you @phl17 and Daisha Jones for the invitation to share awareness of cancer screening and healthy habits for all!! Also had a celebrity guest @misterchewysmidgen www.msn.com/en-us/health... #CancerAwareness #MensHealth
150
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 18/11/2024
Dr. Julie Gralow has joined us at #Medsky 🦋🥳 bsky.app/profile/jrgr...
bsky.app
170
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Pearl Freier @pearlf.bsky.social · 18/11/2024
I'm re-upping this drug development "starter pack" of some Bluesky accounts organized by Greg Medlock—senior director of R&D at Cambridge, MA-based biotech Vedanta Biosciences. See below: #biosky
065
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Paolo Tarantino, MD @ptarantinomd.bsky.social · 17/11/2024
Only 3 weeks to #SABCS24, a meeting that promises to significantly impact the way we treat breast cancer. It will feature phase 3 data with novel SERDs, novel ADCs, immunotherapy, ctDNA monitoring, important biomarker analyses & so much more. Here’s my top 10 abstracts list— see you in San Antonio!
39534
Reposted by Arturo LoAIza-Bonilla, MD MSEd
JPWeiland @jpweiland.bsky.social · 16/11/2024
Ok, this is actually concerning. The sequence of the hospitalized teen with H5N1 has been released. Both of these mutation sites are known to impact α2,6 binding that is needed for human to human transmissibility. Need top experts on H5N1 to immediately to look into this.
20358123
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 14/11/2024
Thrilled to share that @MassiveBio has been named the winner of the Unicorn Kingdom Pathfinder Award (UKPA) for AI by the UK Government's Department for Business and Trade form our commitment to leveraging #AI to connect #cancerpatients with life-changing #clinicaltrials among 400+ global companies!
030
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 14/11/2024
Is anyone concerned about the avian flu case in Canada? Wondering if there is any planning on expanding Audenz #H5N1 vaccine availability to first responders and at risk populations
120
Arturo LoAIza-Bonilla, MD MSEd @drbonillaonc.bsky.social · 14/11/2024
www.science.org/content/arti...
000
Reposted by Arturo LoAIza-Bonilla, MD MSEd
Pearl Freier @pearlf.bsky.social · 12/11/2024
Pfizer's head of digital sciences, Carrie Northcott, spoke w/ @statnews.bsky.social's Mario Aguilar about the use of wearables in their clinical trial for the dangerous cancer-related condition cachexia & how they decided to use digital measures in the study www.statnews.com/2024/11/12/p... #biosky
statnews.com
How Pfizer used wearables to tap into the promise of an experimental drug
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical trials.
041